| For: | Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol 2013; 19(21): 3241-3248 [PMID: 23745025 DOI: 10.3748/wjg.v19.i21.3241] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i21/3241.htm |
| Number | Citing Articles |
| 1 |
Pierre Fwelo, Oladipo Afolayan, Kenechukwu O.S. Nwosu, Akpevwe A. Ojaruega, Onyekachi Ahaiwe, Olajumoke A. Olateju, Ogochukwu Juliet Ezeigwe, Toluwani E. Adekunle, Ayrton Bangolo. Racial and ethnic differences in colon cancer surgery type performed and delayed treatment among people 45 years old and older in the USA between 2007 and 2017: Mediating effect on survival. Surgical Oncology 2023; 50 doi: 10.1016/j.suronc.2023.101983
|
| 2 |
Azah A Althumairi, Mark G Lazarev, Susan L Gearhart. Inflammatory bowel disease associated neoplasia: A surgeon’s perspective. World Journal of Gastroenterology 2016; 22(3): 961-973 doi: 10.3748/wjg.v22.i3.961
|
| 3 |
Massimo Claudio Fantini, Ilaria Guadagni. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Digestive and Liver Disease 2021; 53(5) doi: 10.1016/j.dld.2021.01.012
|
| 4 |
Giacomo Fuschillo, Olga Maria Nardone, Giulio Calabrese, Marc Martí-Gallostra, Francesco Selvaggi, Eloy Espín-Basany, Gianluca Pellino, Jose Perea. Comparative analysis of sporadic, IBD-associated, early-onset and late-onset colorectal cancer: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251379961
|
| 5 |
Luca Roncucci, Francesco Mariani. Prevention of colorectal cancer: How many tools do we have in our basket?. European Journal of Internal Medicine 2015; 26(10) doi: 10.1016/j.ejim.2015.08.019
|
| 6 |
|
| 7 |
Sabrina Jeppsson, Shanthi Srinivasan, Bindu Chandrasekharan. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(2) doi: 10.1152/ajpgi.00410.2015
|
| 8 |
Mark A. Jenkins, Aung K. Win, Noralane M. Lindor. Hereditary Colorectal Cancer. 2018; doi: 10.1007/978-3-319-74259-5_27
|
| 9 |
Carol J. Díaz-Díaz, Sean M. Ronnekleiv-Kelly, Manabu Nukaya, Peter G. Geiger, Silvia Balbo, Romel Dator, Bryant W. Megna, Patrick R. Carney, Christopher A. Bradfield, Gregory D. Kennedy. The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Annals of Surgery 2016; 264(3) doi: 10.1097/SLA.0000000000001874
|
| 10 |
Yifan Li, Huanyu Li, Manli Cui, Ying Zhou, Mingzhen Zhang, Mingxin Zhang. Interaction of Exosomal MicroRNA and Oxidative Stress in the Pathogenesis of Colitis-Associated Cancer. Frontiers in Bioscience-Landmark 2024; 29(8) doi: 10.31083/j.fbl2908276
|
| 11 |
Jingyue Zhang, Chaoyue Chen, Wei Yan, Yu Fu. New sights of immunometabolism and agent progress in colitis associated colorectal cancer. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1303913
|
| 12 |
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, Thorsten Maretzky, Prajwal Gurung, Nandakumar S. Narayanan, Sarah Short, Yiqin Xiong, Zizhen Kang. LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation. Cells 2024; 13(7) doi: 10.3390/cells13070565
|
| 13 |
Rajeev K. Salunke, Murali Dharan, John W. Birk. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; doi: 10.1007/978-3-030-81780-0_11
|
| 14 |
Christof Kaltenmeier, Chengli Shen, David S. Medich, David A. Geller, David L. Bartlett, Allan Tsung, Samer Tohme. Time to Surgery and Colon Cancer Survival in the United States. Annals of Surgery 2021; 274(6) doi: 10.1097/SLA.0000000000003745
|
| 15 |
Alan Askari, Luis Sánchez Guillén, Monica Millan, Subramanian Nachiappan, Alex Bottle, Thanos Athanasiou, Omar Faiz. Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel disease. Surgical Practice 2020; 24(2) doi: 10.1111/1744-1633.12421
|
| 16 |
Christopher C. Taylor, Valentine O. Millien, Jason K. Hou, Nader N. Massarweh. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival. Journal of Surgical Research 2020; 247 doi: 10.1016/j.jss.2019.10.040
|
| 17 |
Hadis Najafimehr, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Hamid Mohaghegh Shalmani, Amir Vahedian-Azimi, Matthew Kroh, Mohammad Reza Zali, Amirhossein Sahebkar, Muhammad Naeem. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer. Gastroenterology Research and Practice 2021; 2021 doi: 10.1155/2021/4874459
|
| 18 |
Paolo Manca, Henry Walch, Jierui Xu, Natalie Small, Ayush Kris, Evan Seffar, Allison Richards, Tiffany Xue, Adam Price, Mark T.A. Donoghue, Christopher Fong, Michele Waters, Justin Jee, Sachin Kumar Deshmukh, George W. Sledge, Midhun Malla, Andrea Cercek, Leonard Saltz, Neil H. Segal, Zsofia K. Stadler, Maliha Nusrat, Michael B. Foote, Avni Desai, Sree Chalasani, Devika Rao, Louise Connell, Richard K.G. Do, Karuna Ganesh, Martin R. Weiser, Michael F. Berger, David B. Solit, Jinru Shia, Efsevia Vakiani, Julio Garcia-Aguilar, Nikolaus Schultz, Francisco Sanchez-Vega, Walid K. Chatila, Rona Yaeger. Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer. Cancer Cell 2026; doi: 10.1016/j.ccell.2026.08.004
|
| 19 |
Mitchell Ramsey, Somashekar G Krishna, Peter P Stanich, Syed Husain, Edward J Levine, Darwin Conwell, Alice Hinton, Cheng Zhang. Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization. Clinical and Translational Gastroenterology 2017; 8(11) doi: 10.1038/ctg.2017.54
|
| 20 |
László Herszényi, Loránd Barabás, Pál Miheller, Zsolt Tulassay. Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk. Digestive Diseases 2015; 33(1) doi: 10.1159/000368447
|
| 21 |
Julia Frebault, Sarah L. Mott, Catherine Tran, Imran Hassan, Schelomo Marmor, Sayeed Ikramuddin, Pridvi Kandagatla, Paolo Goffredo. Defining the Impact of Time to Surgery on Survival after Colon Cancer Diagnosis: A National Trend Analysis. Surgery 2026; doi: 10.1016/j.surg.2026.110611
|
| 22 |
Ramzi Amri, Liliana G. Bordeianou, Patricia Sylla, David L. Berger. Treatment Delay in Surgically-Treated Colon Cancer: Does It Affect Outcomes?. Annals of Surgical Oncology 2014; 21(12) doi: 10.1245/s10434-014-3800-9
|
| 23 |
Baochi Ou, Jingkun Zhao, Shaopei Guan, Aiguo Lu. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis. Digestive Diseases and Sciences 2016; 61(3) doi: 10.1007/s10620-015-3940-1
|
| 24 |
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Boris Galjart, Carsten Kamphues, Timothy M Pawlik, George Poultsides, Klaus Kaczirek, Per Eystein Lønning, Cornelis Verhoef, Martin E Kreis, Christopher L Wolfgang, Matthew J. Weiss. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis. Journal of Surgical Oncology 2018; 118(7) doi: 10.1002/jso.25251
|
| 25 |
Can Lu, Josefine Schardey, Tao Zhang, Alexander Crispin, Ulrich Wirth, Konrad W. Karcz, Alexandr V. Bazhin, Joachim Andrassy, Jens Werner, Florian Kühn. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer. Annals of Surgery 2022; 276(5) doi: 10.1097/SLA.0000000000005339
|